Regeneron (NASDAQ: REGN) reported Q1 EPS of $9.47, $0.50 better than the analyst estimate of $8.97. Revenue for the quarter came in at $3.6 billion versus the consensus estimate of $3.48 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.